The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Thyroid Hormone Therapy for Older Adults with Subclinical Hypothyroidism
Open accessAbstract
BACKGROUND: The use of levothyroxine to treat subclinical hypothyroidism is controversial. We aimed to determine whether levothyroxine provided clinical benefits in older persons with this condition. METHODS: We conducted a double-blind, randomized, placebo-controlled, parallel-group trial involving 737 adults who were at least 65 years of age and who had persisting subclinical hypothyroidism (thyrotropin level, 4.60 to 19.99 mIU per liter; free thyroxine level within the reference range). A total of 368 patients were assigned to receive levothyroxine (at a starting dose of 50 μg daily, or 25 μg if the body weight was <50 kg or the patient had coronary heart disease), with dose adjustment according to the thyrotropin level; 369 patients were assigned to receive placebo with mock dose adjustment. The two primary outcomes were the change in the Hypothyroid Symptoms score and Tiredness score on a thyroid-related quality-of-life questionnaire at 1 year (range of each scale is 0 to 100, with higher scores indicating more symptoms or tiredness, respectively; minimum clinically important difference, 9 points). RESULTS: The mean age of the patients was 74.4 years, and 396 patients (53.7%) were women. The mean (±SD) thyrotropin level was 6.40±2.01 mIU per liter at baseline; at 1 year, this level had decreased to 5.48 mIU per liter in the placebo group, as compared with 3.63 mIU per liter in the levothyroxine group (P<0.001), at a median dose of 50 μg. We found no differences in the mean change at 1 year in the Hypothyroid Symptoms score (0.2±15.3 in the placebo group and 0.2±14.4 in the levothyroxine group; between-group difference, 0.0; 95% confidence interval [CI], -2.0 to 2.1) or the Tiredness score (3.2±17.7 and 3.8±18.4, respectively; between-group difference, 0.4; 95% CI, -2.1 to 2.9). No beneficial effects of levothyroxine were seen on secondary-outcome measures. There was no significant excess of serious adverse events prespecified as being of special interest. CONCLUSIONS: Levothyroxine provided no apparent benefits in older persons with subclinical hypothyroidism. (Funded by European Union FP7 and others; TRUST ClinicalTrials.gov number, NCT01660126 .).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“or to those with persistent subclinical hypothyroidism, where trials do not show a benefit from thyroid hormone replacement. 12,15,16,44 -46”
From Use of liothyronine (T3) in hypothyroidism: Joint British Thyroid Association/Society for endocrinology consensus statement (2023) · cites this paper as [15]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“No clear advantages of treating subclinical hypothyroidism in older individuals (>65 years) have been observed in terms of neurocognitive function and quality of life, 146-148”
From Hypothyroidism (2024) · cites this paper as [147]
The cited source says what the claim attributes to it.
In the citing paper
“large RCTs have shown no improvement in hypothyroid symptoms or quality of life (QoL) in older patients with subclinical hypothyroidism during treatment with levothyroxine. 15 -17”
From Use of liothyronine (T3) in hypothyroidism: Joint British Thyroid Association/Society for endocrinology consensus statement (2023) · cites this paper as [15]
The cited source says what the claim attributes to it.
In the citing paper
“A large placebo-controlled trial among patients with subclinical hypothyroidism at least 65 years of age demonstrated no apparent benefits of LT4 treatment [51].”
From T4+T3 Combination Therapy: An Unsolved Problem of Increasing Magnitude and Complexity (2021) · cites this paper as [51]
In the citing paper
“However, the meta-analysis included a significant proportion of elderly participants (mean age > 65 years) with mild TSH elevations which may reflect the aging process rather than intrinsic thyroid disease [18, 57].”
From Age-related variation in thyroid function – a narrative review highlighting important implications for research and clinical practice (2023) · cites this paper as [18]
In the citing paper
“Likewise, trials of levothyroxine therapy in elderly individuals with mild subclinical hypothyroidism have not shown clinical benefits [18, 57] and it is plausible that TSH elevations in these individuals did not represent intrinsic thyroid failure.”
From Age-related variation in thyroid function – a narrative review highlighting important implications for research and clinical practice (2023) · cites this paper as [18]
In the citing paper
“Neither thyroid symptoms nor tiredness scores were changed significantly in the LT4 or placebo groups by 12 months”
From Pharmacodynamic and Therapeutic Actions of Levothyroxine (2021) · cites this paper as [127]
In the citing paper
“Reassuringly, there were no adverse effects of LT4.”
From Pharmacodynamic and Therapeutic Actions of Levothyroxine (2021) · cites this paper as [127]
In the citing paper
“Although the TSH levels in those on LT4 were reduced impressively, one-quarter of subjects were asymptomatic.”
From Pharmacodynamic and Therapeutic Actions of Levothyroxine (2021) · cites this paper as [127]
In the citing paper
“Confirmation of the elevated TSH is considered essential in establishing the diagnosis of subclinical hypothyroidism although this is not a guarantee of persistent thyroid failure”
From Pharmacodynamic and Therapeutic Actions of Levothyroxine (2021) · cites this paper as [127]
In the citing paper
“A total of 737 patients aged >65 years were recruited and the primary outcome parameter was QoL (Thyroid-Related Quality of Life Patient Reported Outcome [ThyPro] subscales for hypothyroid symptoms score and tiredness score).”
From Pharmacodynamic and Therapeutic Actions of Levothyroxine (2021) · cites this paper as [127]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
EuroQol: a new facility for the measurement of health-related quality of life
(1990) · Health Policy · doi:10.1016/0168-8510(90)90421-9 · Cited by 15,736
The Colorado Thyroid Disease Prevalence Study
Canaris, G. J., Manowitz, N. R., Mayor, G., & Ridgway, E. C. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.4.526 · Cited by 2,824
Katz, S. (1963) · JAMA · doi:10.1001/jama.1963.03060120024016 · Cited by 2,421
Subclinical Hypothyroidism and the Risk of Coronary Heart Disease and Mortality
Rodondi, N., den Elzen, W. P. J., Bauer, D. C., Cappola, A. R., Razvi, S., Walsh, J. P., Åsvold, B. O., Iervasi, G., Imaizumi, M., Collet, T.-H., et al. (2010) · JAMA · doi:10.1001/jama.2010.1361 · Cited by 1,216
Self-citation2013 ETA Guideline: Management of Subclinical Hypothyroidism
Pearce, S. H. S., Brabant, G., Duntas, L. H., Monzani, F., Peeters, R. P., Razvi, S., & Wemeau, J.-L. (2013) · European Thyroid Journal · doi:10.1159/000356507 · Cited by 877
Fade, J. V., Franklyn, J. A., Cross, K. W., Jones, S. C., & Sheppard, M. C. (1991) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1991.tb01739.x · Cited by 567
Razvi, S., Ingoe, L., Keeka, G., Oates, C., McMillan, C., & Weaver, J. U. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1869 · Cited by 389
Grip Strength in Healthy Caucasian Adults: Reference Values
Günther, C., Bürger, A., Rickert, M., Crispin, A., & Schulz, C. U. (2008) · The Journal Of Hand Surgery · doi:10.1016/j.jhsa.2008.01.008 · Cited by 366
Monzani, F., Di Bello, V., Caraccio, N., Bertini, A., Giorgi, D., Giusti, C., & Ferrannini, E. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7291 · Cited by 308
Flagged first, then by citations
Research works printed but not linked: 4
- Baumgartner C, 2015, Swiss Med Wkly, 145, w14156
- Villar HC, 2007, Cochrane Database Syst Rev, 3, CD003419
- Mahoney FI, 1965, Md State Med J, 14, 61
- McClure NS, Value Health
Cited by
Sorted by citations
Items 401–499 of 499
Treatment of Older Adults With Subclinical Hypothyroidism—Reply
Mooijaart, S. P., & Puy, R. S. D. (2020) · JAMA · doi:10.1001/jama.2020.0948
Self-citationPingitore, A., & Mastorci, F. (2020) · Springer eBooks · doi:10.1007/978-3-030-36871-5_29
Modalities of Thyroid Hormone Administration and Correlates Between Blood and Tissue Levels
Celi, F. S. (2020) · Springer eBooks · doi:10.1007/978-3-030-36871-5_26
Slagboom, P. E., & van Heemst, D. (2020) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-368-2453-8_2
Dominguez, L. J., & Barbagallo, M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11338-8
Tugendsam, C., & Kurtaran, A. (2020) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-020-00761-2
Thyroid hormone, thyroid medication, and the skeleton
Freudenthal, B., Watts, L., Bassett, J. H. D., & Williams, G. R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813073-5.00046-0
Thyroid replacement therapy effects on cardiac function in patients with hypothyroidism
Djenić, A., & Obrenović-Kirćanski, B. (2020) · Srpski arhiv za celokupno lekarstvo · doi:10.2298/sarh200828107d
Challenges in Defining and Studying Subclinical Hypothyroidism in Older Adults
Modarressi, T. (2020) · The American Journal of Medicine · doi:10.1016/j.amjmed.2020.08.024
Angell, T. E. (2020) · Clinical Thyroidology · doi:10.1089/ct.2020;32.544-547
Individualized prevention in cardiovascular disease and diabetes mellitus
de Vries, T. I. (2020) · doi:10.33540/352
Weniger ist mehr … in der hausärztlich-internistischen Praxis
Schorrlepp, M., & Burchert, D. (2021) · Der Internist · doi:10.1007/s00108-021-00956-8
Schilddrüsenerkrankungen in der Peri- und Postmenopause
Mondorf, A. W., Meyer, G., & Bojunga, J. (2021) · Journal für Gynäkologische Endokrinologie/Schweiz · doi:10.1007/s41975-021-00186-z
Elsherbiny, T. M. (2019) · The Egyptian Journal of Internal Medicine · doi:10.4103/ejim.ejim_79_19
La terapia dell’ipotiroidismo subclinico
Magri, F., Liboà, F., Bendotti, G., & Chiovato, L. (2021) · L Endocrinologo · doi:10.1007/s40619-021-00863-y
Levothyroxine Is Overprescribed More Than You Realize
Drake, T. C. (2021) · Clinical Thyroidology · doi:10.1089/ct.2021;33.339-341
Thyroid Dysfunction and Metabolism: Diagnosis and Follow-Up
Luzi, L., Massarini, S., Terruzzi, I., Ferrulli, A., & Cusini, C. (2021) · Springer eBooks · doi:10.1007/978-3-030-80267-7_11
Subclinical endocrine diseases: a never-ending challenge
Pontecorvi, A., & Gelli, S. (2021) · Minerva Endocrinology · doi:10.23736/s2724-6507.21.03530-2
Pathophysiological aspects of development myocardial infarction type 2 in subclinical hypothyroidism
Ivannikov, A. A., Kanibolotskiy, A. A., Алиджанова, Х. Г., & Bratischev, I. V. (2021) · Medical alphabet · doi:10.33667/2078-5631-2021-42-34-41
Health Literacy and Patient -Reported Outcomes
Bellini, M. I., & Kübler, A. (2021) · IGI Global eBooks · doi:10.4018/978-1-6684-2414-8.ch012
Thyroid Disorders and Bone Disease
Watts, L. M., Freudenthal, B., Bassett, J. H. D., & Williams, G. R. (2022) · doi:10.1093/med/9780198870197.003.0089
Clinical Assessment and Systemic Manifestations of Hypothyroidism
Tonacchera, M., & Chiovato, L. (2022) · doi:10.1093/med/9780198870197.003.0067
Valencia, W. M., & Florez, H. J. (2021) · Springer eBooks · doi:10.1007/978-3-030-76271-1_20
Bourey, R. E., Morley, J. E., & McKee, A. M. (2022) · Wiley eBooks · doi:10.1002/9781119484288.ch81
Dominguez, L. J., & Barbagallo, M. (2022) · Wiley eBooks · doi:10.1002/9781119484288.ch83
Choksi, P. U., & Lash, R. W. (2018) · doi:10.1093/med/9780190862800.003.0079
Gencer, B., Bauer, D. C., & Rodondi, N. (2020) · The American Journal of Medicine · doi:10.1016/j.amjmed.2020.09.008
Self-citation7 Medical Management of Thyroiditis and Hypothyroidism
(2021) · Thieme Medical Publishers eBooks · doi:10.1055/b-0041-182782
Ladsous, M., & Wémeau, J.-L. (2018) · EMC - AKOS - Trattato di Medicina · doi:10.1016/s1634-7358(18)91695-5
Grani, G. (2022) · Clinical Thyroidology · doi:10.1089/ct.2022;34.199-201
Hypothyroidism and Levothyroxine, Review Article
Akhtar, W., Moghal, F. A., Ishaq, M., Naseem, A., Rana, A. H., Nadeem, H., Huda, M. N. U., Barki, K. M. E., Naseem, S., & Shaikh, M. Z. (2022) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs22164630
Kim, K. E., Do, M. H., Geum, M. J., Kim, J. S., Son, E. S., & Yu, Y. M. (2022) · Journal of Korean Society of Health-System Pharmacists · doi:10.32429/jkshp.2022.39.2.002
Jackson, K., Simons, Z., & Moseley, K. F. (2022) · Cambridge University Press eBooks · doi:10.1017/9781108942751.031
Robertson, M. L., & Colburn, J. L. (2022) · Cambridge University Press eBooks · doi:10.1017/9781108942751.004
LaVine, N. (2022) · Springer eBooks · doi:10.1007/978-3-031-15353-2_8
Netea-Maier, R. T. (2021) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-368-2707-2_20
Rupani, S. V., & Kotwal, A. (2023) · Clinical Thyroidology · doi:10.1089/ct.2023;35.131-134
Treatment of Subclinical Hypothyroidism; A Review of Literature
Mughal, A. A., Abbas, S. T., Asad, H., Zubair, M., & Mujeeb, R. (2023) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs2023172787
Jiang, C., Wolf, K., Kaakati, R. N., Oh, J., Yip, A. T., Jonklaas, J., Bianco, A. C., Laiteerapong, N., & Ettleson, M. D. (2023) · Endocrine Practice · doi:10.1016/j.eprac.2023.07.031
Jobst, D., Schübel, J., Uebel, T., & Chenot, J. (2023) · Elsevier eBooks · doi:10.1016/b978-3-437-23327-2.00013-2
Schilddrüsenfunktionsstörungen im Alter
Iwen, A. (2023) · Angewandte Nuklearmedizin · doi:10.1055/a-2030-6758
TSH Spontaneously Normalizes in Many Older Adults with Subclinical Hypothyroidism
Cubb, T. D. (2023) · Clinical Thyroidology · doi:10.1089/ct.2023;35.491-494
Stijgend gebruik van levothyroxine in België
Boets, L., den Bruel, A. V., haecht, C. V., Cornelis, K., Debbaut, B., Ntahonganyira, R.-M., Flamaing, J., Stokx, J., & Decallonne, B. (2024) · Tijdschrift voor Geneeskunde · doi:10.47671/tvg.79.23.122
Мodern achievement and issues in primary hypothyroidism treatment
Николаева, А. В., Валерьевич, Д. М., Пименов, Л. Т., & Resnik, E. V. (2024) · Clinical Medicine (Russian Journal) · doi:10.30629/0023-2149-2023-101-12-613-622
Hypothyroidism: Pathophysiology and Management
Virippil, N., Merck, A., Beckett, E., Exley, S., & Kabadi, U. M. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1004851
Amiodarone-induced thyropathies
Bystrianska, M., Bystriansky, A., & Wildová, I. (2024) · Vnitřní lékařství · doi:10.36290/vnl.2024.054
Bushra, H., & Rashid, M. (2024) · Avicenna Journal of Medicine · doi:10.1055/s-0044-1788040
Exploring the potential of thyroid hormone therapy: Recent advancements and controversies
Sai, Y. R. K. M. (2024) · International Journal of Clinical Endocrinology and Metabolism · doi:10.17352/ijcem.000059
Role of thyroid hormones in the implementation of adaptive reactions of the organism
Shatyr, J. A., Олегович, Н. Н., & Glushakov, R. I. (2024) · Сибирский научный медицинский журнал · doi:10.18699/ssmj20240306
Zhang, P., & Gao, Y. (2025) · Clinical Thyroidology · doi:10.1089/ct.2025;37.91-94
Maushart, C. I., & Betz, M. J. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00248-x
Ladsous, M. (2025) · La Presse Médicale Formation · doi:10.1016/j.lpmfor.2025.100668
Special Considerations in the Treatment of Hypothyroidism
Hoermann, R., & Dietrich, J. W. (2025) · Springer eBooks · doi:10.1007/978-981-96-3682-2_12
The Concept of Relational Stability
Hoermann, R., & Dietrich, J. W. (2025) · Springer eBooks · doi:10.1007/978-981-96-3682-2_2
Hashimoto, K. (2025) · Clinical Thyroidology · doi:10.1089/ct.2025;37.242-244
Maia, I. G. M., Braulino, P. D. M., Santos, M. M., Ferreira, B. X. T., Melo, H. C. D. O., Griz, L., Maia, A. G., & Palhares, L. F. N. (2025) · Revista de Medicina · doi:10.11606/issn.1679-9836.v104i5e-234809
Cardiovascular Manifestations of Thyroid Disorders: Mechanisms, Diagnosis, and Management
Tannous, L., Agrawal, S. P., Tated, R. C. P., Paramba, T., Maheta, D., Jain, H., Frishman, W. H., & Aronow, W. S. (2025) · Cardiology in Review · doi:10.1097/crd.0000000000001104
Thyroid dysfunction in ageing populations
van Heemst, D. (2025) · Endocrine Connections · doi:10.1530/ec-25-0185
Holley, M., Razvi, S., Farooq, M. S., Dew, R., Maxwell, I., & Wilkes, S. (2024) · Figshare · doi:10.6084/m9.figshare.25779322
van Vliet, N. A., Bos, M. M., Thesing, C. S., Chaker, L., Pietzner, M., Houtman, E., Neville, M. J., Li‐Gao, R., Trompet, S., Mustafa, R., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16921616
Self-citationLarsen, C. B., Winther, K. H., Cramon, P. K., Rasmussen, Å. K., Feldt‐Rasmussen, U., Groenvold, M., Bjorner, J. B., Hegedüs, L., Watt, T., & Bonnema, S. J. (2024) · Figshare · doi:10.6084/m9.figshare.26614339
Self-citationAnalysis of Progression and Risk Factors in Chinese Population With Mild‐Subclinical Hypothyroidism
Xu, S., Zhang, A., Yang, R., Xiong, Y., Zhao, L., Yang, J., Zhu, J., Pan, B., Guo, W., Shao, W., et al. (2025) · International Journal of Clinical Practice · doi:10.1155/ijcp/8862604
Zhang, R., Zhou, Y., Wang, S. L., Li, F., Zhao, X., Jia, B., Li, X., Yang, J., Yang, L., Yu, H., et al. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2025.1710962
Age-related reference intervals for thyroid function tests are beneficial in adults over 60 years
Allen, G. F. G., Blampied, S., Patel, K. A., McDonald, T. J., Hattersley, A. T., & Vaidya, B. (2026) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/00045632261426852
Iodine for Health and Longevity
Riis, J., Thomsen, M. J., Andersen, S. L., & Andersen, S. (2026) · Healthy ageing and longevity · doi:10.1007/978-3-032-11608-6_7
Орлик, О. С. (2026) · Український медичний часопис · doi:10.32471/umj.1680-3051.273711
Measuring Impact of Benign Thyroid Diseases on Quality of Life
Watt, T. (2019) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00421-0
Self-citationKurzweil, E., Nissan, R., Sharir-Levy, D., Elazar, A., Kornyukov, N., & Hershkovitz, A. (2026) · Archives of Gerontology and Geriatrics Plus · doi:10.1016/j.aggp.2026.100267
Exploring Quality of Life Among Thyroid Patients in South Indian Communities: A Comprehensive Study
Baraka, B. B. H., Jambigi, K., Gopal, N., Shivani Verma, R., Sahana, S., & Sidaray, K. A. (2025) · International Journal of Pharmaceutical Sciences and Drug Research · doi:10.25004/ijpsdr.2025.170602
Additional treatment strategies for hypothyroidism: a network meta-analysis
Lv, X., Qin, W., Li, J., & Likun, D. (2026) · Endocrine Connections · doi:10.1530/ec-26-0011
Diagnostik und Therapie von Schilddrüsenfunktionsstörungen unter Amiodaron
Schnider, J., Auer, M. K., & Pappa, E. (2026) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/a-2735-3729
What is an optimal serum thyroid-stimulating hormone value in older adults?
Pearce, E. N. (2026) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(26)00031-8
徐, 郝. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.1651864
Lu, J., Tang, C.-M., Ge, G. M., Cheng, K. K., Lee, K. Y., Tan, K. C. B., Lam, S. K. K., Cheung, E. Y., Cheung, C., & Li, G. H. (2026) · BMC Medicine · doi:10.1186/s12916-026-04942-5
Deprescribing Levothyroxine in Older Adults: Time to Challenge the “Lifelong” Dogma?
Toro-Tobón, D. (2026) · Clinical Thyroidology · doi:10.1177/23299711261448638
Gandhi, A. P., Deshmukh, K. P., Kaliyappan, A., Bang, A., & Gangane, N. (2026) · F1000Research · doi:10.12688/f1000research.179360.1
Patel, M., Tiwari, D., Anwar, S., Evans, P. H., Meersschaert, C., Minhas, J. S., Masoli, J. A. H., & Quinn, T. J. (2026) · Age and Ageing · doi:10.1093/ageing/afag143
Self-citationPamnani, I., Pamnani, G., & Nagar, D. H. K. (2026) · International Journal For Multidisciplinary Research · doi:10.36948/ijfmr.2026.v08i03.79907
Less Can Be More: Pragmatic Levothyroxine Use in the Elderly in the Era of Deprescribing
Kamrul-Hasan, A. B. M., Ahammed, A., Saifuddin, M., & Selim, S. (2026) · AACE Endocrinology and Diabetes · doi:10.1016/j.aed.2026.05.006
Gray-zone decisions in subclinical hypothyroidism: a qualitative analysis of ChatGPT responses
Vuraloğlu, E. (2026) · BMC Endocrine Disorders · doi:10.1186/s12902-026-02356-1
Thyroid-Liver Axis: Mechanistic Insights and Clinical Implications
Parveen, N., Chittawar, S., Khandelwal, D., & Aggarwal, S. (2026) · Cureus · doi:10.7759/cureus.110637
Thyrotropin Targets in the Elderly: New Data from the Largest Observational Study so Far
Osinga, J. A. J. (2026) · Clinical Thyroidology · doi:10.1177/23299711261458114
Kopanos, S., Feldkamp, J. D., Tyssen, J., Li, X., Sundquist, K., Pape-Köhler, C., Binnebösel, M., Hoyer, A., Wändell, P. E., & Feldkamp, J. (2026) · Metabolites · doi:10.3390/metabo16070465
Elagib, M. A. H., Alamin, M. A., Ahmed, Y. O. A., Musa, I. E. M., Khaleifa, M. A., Elsamani, E. A. E. M., Najar, H., & Ahmed, A. (2026) · Cureus · doi:10.7759/cureus.114468
Higher Prevalence of Subclinical Hypothyroidism in Croatian War Veterans: A Cross-Sectional Study
Pavičić, D., Romić, Z. Č., Čurić, J., Rajković, I., Rajković, I., Glasnović, A., Prkačin, I., Rahelić, D., Bulum, T., Tešanović, S., et al. (2026) · Epidemiologia · doi:10.3390/epidemiologia7040113
Subclinical Thyroid Dysfunction: When to treat and when to observe. A comprehensive clinical review
Rzepka, H., Stępowski, P., & Tajster, M. (2026) · Journal of Education Health and Sport · doi:10.12775/jehs.2026.95.73650
An overview of the consequences of subclinical hypothyroidism
Mach, T., & Yu, O. H. Y. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-30261-9.00004-8
Levothyroxine and effects on the brain: MRI and beyond
Sahu, S., Younas, S., Nafees, M., Farooq, S., Rajendram, R., & Preedy, V. R. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-30261-9.00020-6
SONY, V., R, B., & Brahmanandam, L. (2026) · Indian Journal of Forensic and Community Medicine · doi:10.18231/j.ijfcm.15636.1784286488
Primary Hypothyroidism in Older Adults: Do Current Guidelines Need an Update?
Matyas, A., Ziajka, P., Zwolińska, A., Gaudynek-Sowała, A., Łapot, M., Szczepanek, G., Lurka, H., Zyskowska, A., Starczewski, M., Tomczak, A., et al. (2026) · Quality in Sport · doi:10.12775/qs.2026.77.76055
Peralta, M. M. G., Yaguana, M. B. V., Alarcón, W. A. Z., Zambrano, E. C. M., & Párraga, A. M. A. (2026) · Ciencia Unemi · doi:10.29076/issn.2528-7737vol19iss52.2026pp13-23p
Diretriz Brasileira de Insuficiência Cardíaca – 2026
Simões, M. V., Moura, L. Z., Martins, S. M., Mourilhe‐Rocha, R., Danzmann, L. C., Neto, J. A. D. F., Marcondes‐Braga, F. G., de Oliveira, M. T., de Albuquerque, D. C., Freitas, A. F., et al. (2026) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20260830
Andrade, L. J. D. O., de Oliveira, G. C. M., Salles, O. J. D. M., Ludovico, N. D., Al, B., & de Oliveira, L. M. (2026) · Research Square · doi:10.21203/rs.3.rs-11382018/v1
Subclinical Hypothyroidism: Who Should Be Treated and Who Can Be Observed?
Mareh, M. M. (2026) · Cureus · doi:10.7759/cureus.118302
Thyroid Disorders in Older Adults
Pandya, N., Katib, H., & Santiago, L. (2026) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2026.09.002
Toloza, F. J. K., Ho, K., Burgos, N., Ospina, N. S., Maraka, S., Salloum, R. G., Hassett, L. C., Papaleontiou, M., Mammen, J. S., & Brito, J. P. (2026) · Thyroid · doi:10.1177/10507256261502928
Gonzales, C., Theisen, E., Sarau, A., Kim, J., Landek, D., Bianco, A. C., & Volgman, A. S. (2026) · medRxiv · doi:10.64898/2026.10.30.26366962
Metadata
- Authors
- Stott, D. J., Rodondi, N., Kearney, P. M., Ford, I., Westendorp, R. G. J., Mooijaart, S. P., Sattar, N., Aubert, C. E., Aujesky, D., Bauer, D. C., Baumgartner, C., Blum, M. R., Browne, J. P., Byrne, S., Collet, T.-H., Dekkers, O. M., den Elzen, W. P. J., Du Puy, R. S., Ellis, G., Feller, M., Floriani, C., Hendry, K., Hurley, C., Jukema, J. W., Kean, S., Kelly, M., Krebs, D., Langhorne, P., McCarthy, G., McCarthy, V., McConnachie, A., McDade, M., Messow, M., O’Flynn, A., O’Riordan, D., Poortvliet, R. K. E., Quinn, T. J., Russell, A., Sinnott, C., Smit, J. W. A., Van Dorland, H. A., Walsh, K. A., Walsh, E. K., Watt, T., Wilson, R., & Gussekloo, J.
- Affiliations
- University of Bern (CH)
- ORCID
- Stott, David J.
- Rodondi, Nicolas
- Kearney, Patricia M.
- Ford, Ian
- Westendorp, Rudi G.J.
- Mooijaart, Simon P.
- Sattar, Naveed
- Aubert, Carole E.
- Aujesky, Drahomir
- Bauer, Douglas C.
- Baumgartner, Christine
- Blum, Manuel R.
- Browne, John P.
- Byrne, Stephen
- Collet, Tinh-Hai
- Dekkers, Olaf M.
- Ellis, Graham
- Feller, Martin
- Hurley, Caroline
- Jukema, J. Wouter
- Kean, Sharon
- Langhorne, Peter
- McConnachie, Alex
- Poortvliet, Rosalinde K.E.
- Quinn, Terence J
- Russell, Audrey
- Sinnott, Carol
- Walsh, Kieran A.
- Walsh, Elaine K.
- Watt, Torquil
- Gussekloo, Jacobijn
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2017-06-29
- Volume
- 376
- Issue
- 26
- Pages
- 2534-2544
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2604882706
- Cited by
- 490
- References
- 25
- Citations by year
- 2026: 42 · 2025: 28 · 2024: 43 · 2023: 47 · 2022: 54 · 2021: 61 · 2020: 62 · 2019: 61 · 2018: 64 · 2017: 27
- FWCI
- 46.23
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion, other-oa)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
- SERVAL (Université de Lausanne) (publishedVersion, other-oa)
- Archive ouverte UNIGE (University of Geneva) (publishedVersion, other-oa)
- Arrow@dit (Dublin Institute of Technology) (acceptedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- IRIS (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- BORIS (University Library Bern) (submittedVersion, other-oa)
- Cork Open Research Archive (University College Cork, Ireland) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Apollo (University of Cambridge) (submittedVersion)
- Apollo
- Funders
- National Science Foundation
- Velux Stiftung
- University of Bern
- Health Research Board (SPHeRE/2013/1)
- Inselspital, Universitätsspital Bern
- European Commission (278148, FP7‐HEALTH‐2011)
- University of Glasgow
- University College Cork
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (165409, 320 030-150 025, 150025, 278148, 167826, 320030)
- Universiteit Leiden
- Radboud Universiteit
- Gentofte Hospital
- Schweizerische Herzstiftung (278148)
- Leids Universitair Medisch Centrum
- Rigshospitalet
- Radboud Universitair Medisch Centrum
- University of California, San Francisco
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (K24AR051895)
- FP7 Health
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- subclinical hypothyroidism, levothyroxine, thyroid hormone replacement, older adults, quality of life, fatigue, thyroid-stimulating hormone, dose adjustment, coronary artery disease, body weight, cost-effectiveness, patient-reported outcomes, health-related quality of life
- MeSH terms
- Aged, Aged, 80 and over, Double-Blind Method, Fatigue, Female, Humans, Hypothyroidism, Male, Quality of Life, Thyrotropin, Thyroxine, Treatment Failure, Intention to Treat Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
